MiniMed™ 670G Insulin Pump System

Insulin pump technology that automatically adjusts background insulin every 5 minutes based on a body’s unique needs.*

For people with type 1 diabetes ages 7 and up.

MiniMedTM 670G System


BENEFITS of MiniMedTM 670G System

Here are some of the benefits people can experience when using the MiniMed™ 670G system.

Timer icon 5 minutes


The system automatically changes the amount of background insulin you receive based on your body’s needs.

Push Button Icon


The system allows you to deliver insulin through a small tube that is hidden under your clothing, rather than manual injections.

Utensil Icon


With the push of a button, you can give yourself insulin.

Two levels of SmartGuard™ Automation for Customized Therapy

  • Auto Mode automatically adjusts basal insulin every five minutes based on the patient’s continuous glucose monitoring (CGM) readings, helping to keep sugar levels in the target range for fewer lows and highs — day and night.*†3
  • Manual Mode with the Suspend before low option proactively addresses lows and rebound highs by automatically suspending insulin before patients reach a pre-selected low glucose limit, resuming delivery when sensor glucose levels recover.2




  • Our most accurate sensor with a MARD of 8.7%*,||
  • Approved for abdomen and back of arm use.
  • Easy insertion and flexible design make it comfortable for your patients to wear every day.
  • Continuously lets your patients know where their glucose levels are and see their trends.

Guardian Sensor 3 on white background


Expand All


Waterproof pump, protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.


Environmental Conditions

Pump Memory

Compatible Infusion Sets

Guardian™ Link 3 Transmitter

Bolus Speed Options

Bolus Programming Increments

Altitude Range


Basal Delivery Rate Range

Guardian™ Sensor 3

CareLink™ USB

One-Press Serter

Battery and Power


CONTOUR®NEXT LINK 2.4 Glucose Meter


pdf MiniMed™ 670G System Protocol: Interpreting CareLink™ Reports (.pdf)

Learn protocol for interpreting CareLink™ Auto Mode reports.


pdf MiniMed™ 670G System Protocol: Identifying Patients (.pdf)

Learn protocol for identifying patients and setting expectations.


pdf MiniMed™ 670G System Protocol: Transitioning to Hybrid Closed Loop Therapy (.pdf)

Understand protocol for transitioning patients to the MiniMed™ 670G hybrid closed loop system.


pdf Learn the Basics: Diabetes, Insulin Pump Therapy, and Carb Counting with the MiniMed™ 670G System (.pdf)

Guide to the basics of diabetes and how the body works, insulin pump therapy, and carbohydrate counting.


pdf The ABCs of Managing SmartGuard™ Auto Mode (.pdf)

Learn a simple approach to managing SmartGuard™ Auto Mode.



On-demand videos offer practical tips from clinical experts for using Medtronic Diabetes therapies to help you support patients.



Engage with real-world case studies and explore special considerations for therapy management.



Browse our library to find reference materials for your Medtronic Diabetes products.


Refers to SmartGuard™ Auto Mode feature; The MiniMed™ 670G system can automatically increase or decrease insulin delivery based on continuous glucose monitoring (CGM) values; however, the user must still administer meal boluses. ADA recommendation for a glucose range is 80-180 mg/dL in non-pregnant adults with diabetes. Based on clinical study data in pivotal trial. Individual results may vary.

Based on sensor glucose.

Approved for ages 14 and older.


Refers to AutoMode. Some interaction required. Individual results may vary.


Arm sensor insertion site, 3-4 calibrations/day. Approved for ages 14-75 years.

At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.


Gopalakrishnan S, Mueckler J, Fogel C. The MiniMed™ 670G hybrid closed loop system & patient reported outcomes concerning quality of life measures (n=2.S34). Poster #963-P presented at the 78th Scientific Sessions of the American Diabetes Association: 2018 June 22 26, Orlando, Florida, USA.


Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407-1408


dQ&A Patient Panel. [Q4 2016 Summary Report]. dQ&A 2017.

Important Safety Information: MiniMed™ 670G System

The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.

WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.

© 2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Ascensia Diabetes Care Logo

Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.